Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardio Diagnostics Holdings (CDIO) Operating Expenses (2021 - 2025)

Cardio Diagnostics Holdings' Operating Expenses history spans 5 years, with the latest figure at $1.7 million for Q3 2025.

  • For Q3 2025, Operating Expenses rose 21.12% year-over-year to $1.7 million; the TTM value through Sep 2025 reached $6.6 million, down 22.24%, while the annual FY2024 figure was $8.4 million, 15.72% up from the prior year.
  • Operating Expenses for Q3 2025 was $1.7 million at Cardio Diagnostics Holdings, up from $1.7 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $4.2 million in Q1 2024 and bottomed at $397.0 in Q2 2021.
  • The 5-year median for Operating Expenses is $1.5 million (2023), against an average of $1.3 million.
  • The largest annual shift saw Operating Expenses soared 198127.71% in 2022 before it plummeted 60.91% in 2025.
  • A 5-year view of Operating Expenses shows it stood at $20887.0 in 2021, then soared by 11289.89% to $2.4 million in 2022, then crashed by 34.96% to $1.5 million in 2023, then dropped by 1.71% to $1.5 million in 2024, then rose by 12.73% to $1.7 million in 2025.
  • Per Business Quant, the three most recent readings for CDIO's Operating Expenses are $1.7 million (Q3 2025), $1.7 million (Q2 2025), and $1.6 million (Q1 2025).